BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1349763)

  • 1. Meta-analysis for 2 x 2 tables: a Bayesian approach.
    Carlin JB
    Stat Med; 1992 Jan; 11(2):141-58. PubMed ID: 1349763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining event rates from clinical trials: comparison of Bayesian and classical methods.
    Su XY; Li Wan Po A
    Ann Pharmacother; 1996 May; 30(5):460-5. PubMed ID: 8740323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic meta-analysis of contingency tables.
    Casella G; Moreno E
    Stat Med; 2005 Feb; 24(4):583-604. PubMed ID: 15678406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixtures of prior distributions for predictive Bayesian sample size calculations in clinical trials.
    Brutti P; De Santis F; Gubbiotti S
    Stat Med; 2009 Jul; 28(17):2185-201. PubMed ID: 19462415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robustness considerations in Bayesian analysis.
    Gustafson P
    Stat Methods Med Res; 1996 Dec; 5(4):357-73. PubMed ID: 9004378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borrowing strength from external trials in a meta-analysis.
    Higgins JP; Whitehead A
    Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
    Odani M; Fukimbara S; Sato T
    Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian robustness in meta-analysis for studies with zero responses.
    Vázquez FJ; Moreno E; Negrín MA; Martel M
    Pharm Stat; 2016 May; 15(3):230-7. PubMed ID: 26913715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian meta-analysis: The role of the between-sample heterogeneity.
    Moreno E; Vázquez-Polo FJ; Negrín MA
    Stat Methods Med Res; 2018 Dec; 27(12):3643-3657. PubMed ID: 28511616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction.
    Higgins JP; Spiegelhalter DJ
    Int J Epidemiol; 2002 Feb; 31(1):96-104. PubMed ID: 11914302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting Bayesian analyses of clinical trials.
    Hughes MD
    Stat Med; 1993 Sep; 12(18):1651-63. PubMed ID: 7902601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian Equivalence Testing and Meta-Analysis in Two-Arm Trials with Binary Data.
    Kpekpena C; Muthukumarana S
    Comput Math Methods Med; 2018; 2018():8134132. PubMed ID: 30159005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline risk as predictor of treatment benefit: three clinical meta-re-analyses.
    Arends LR; Hoes AW; Lubsen J; Grobbee DE; Stijnen T
    Stat Med; 2000 Dec; 19(24):3497-518. PubMed ID: 11122510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian estimation in random effects meta-analysis using a non-informative prior.
    Bodnar O; Link A; Arendacká B; Possolo A; Elster C
    Stat Med; 2017 Jan; 36(2):378-399. PubMed ID: 27790722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian sensitivity study of risk difference in the meta-analysis of binary outcomes from sparse data.
    Vázquez-Polo FJ; Moreno E; Negrín MA; Martel M
    Expert Rev Pharmacoecon Outcomes Res; 2015 Apr; 15(2):317-22. PubMed ID: 25673174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian approaches to meta-analysis of ROC curves.
    Hellmich M; Abrams KR; Sutton AJ
    Med Decis Making; 1999; 19(3):252-64. PubMed ID: 10424832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Bayesian inference to perform meta-analysis.
    Schmid CH
    Eval Health Prof; 2001 Jun; 24(2):165-89. PubMed ID: 11523385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer.
    Steenland K; Greenland S
    Am J Epidemiol; 2004 Aug; 160(4):384-92. PubMed ID: 15286024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian analysis of proportional hazards models built from monotone functions.
    Gelfand AE; Mallick BK
    Biometrics; 1995 Sep; 51(3):843-52. PubMed ID: 7548703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does atenolol differ from other beta-adrenergic blockers?
    Aursnes I; Osnes JB; Tvete IF; Gåsemyr J; Natvig B
    BMC Clin Pharmacol; 2007 May; 7():4. PubMed ID: 17488499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.